None of the main childhood vaccines in England reached their uptake targets in 2024/25, new figures have revealed.
Some 91.9% of five-year-olds have received one dose of the MMR (measles, mumps and rubella) vaccine, the UK Health Security Agency (UKHSA) has said.
The figure remains unchanged from the previous year and the lowest level since 2010/2011.
Just 83.7% of children aged five had received both MMR doses, down year-on-year from 83.9%, and the lowest level since 2009/10.
The uptake target for all childhood vaccines is 95%.
Coverage for the Hib/MenC vaccine, which protects against haemophilus influenzae type B and meningitis C, stood at 88.9% for children in England aged five. This is down from 89.4% in 2023/24 and the lowest level since 2011/12.
Meanwhile, some 91.4% of children had completed their primary course of the six-in-one vaccine by the age of 12 months, up year-on-year from 91.2%.
The six-in-one jabs protect against diphtheria, pertussis, tetanus, polio, disease caused by Haemophilus influenzae type B, and hepatitis B.
Read more:
Why are childhood vaccine rates so low?
Bereaved mum urges parents to book kids’ vaccinations
Uptake of the four-in-one pre-school booster vaccine – which helps protect against polio, whooping cough, tetanus and diphtheria – stood at just 81.4% among five-year-olds in England in 2024/25, the lowest rate since current data began in 2009/10.
London lags behind national averages
The UKHSA tracks vaccination coverage from April to March, in line with the financial year.
Its annual report has also revealed regional variations in the figures – showing London often lagging behind the national average.
Overall, 83.7% of five-year-olds have received both MMR vaccines, but just 69.6% of those in the capital have.
Follow our channel and never miss an update
Please use Chrome browser for a more accessible video player
Take-up of the Hib/MenC vaccine among five-year-olds peaks at 93.5% in south-west England, going down to 80% in London.
The capital also has the lowest regional average for uptake of the six-in-one vaccine by the age of 12 months (at 86.3%) and the six-in-one vaccine at the age of five (86.5%).
